Albany – NY, Dec. 21, 2017 -- Zimmer Biomet, Stryker Corporation, and DePuy Synthes have been the three leaders in the global osteosynthesis devices market for 2014, with a giant collective share in the market stood at 83.7%, according to a research report recently published by Transparency Market Research. The leaders in this highly consolidated market have proven themselves through a extensive product portfolios added to a string of successful mergers and acquisitions. For example, merger between Johnson & Johnson or DePuy with Synthes enabled the formation of a leading provider for osteosynthesis devices in the world.
View Report at https://www.transparencymarketresearch.com/osteosynthesis-devices-market.html
The research report reveals that the global market for osteosynthesis devices is expected to reach US$11 bn by the end of 2023, after expanding at a CAGR of 6.5% from 2015 to 2023 in revenue. This revenue was slated to go over US$6.6 bn in 2016. Asia Pacific is expected to be an attractive region for the supply of osteosynthesis devices over the coming years, due to a swiftly evolving healthcare infrastructure and growing healthcare expenditure. North America, on the other hand, is likely to continue dominating both revenue and demand for osteosynthesis devices for the given forecast period. Non-degradable materials have so far been the more popular material type for the manufacture of osteosynthesis devices till 2023 and are likely to remain in the lead over the given forecast period by TMR. Internal fixation devices are expected to continue being the more popular type of osteosynthesis devices over the coming years.
Request to View Sample Copy of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5981
The threat for new entrants is likely to remain moderate to low over the coming years, according to the TMR report. The presence of very strong players, high entry costs, and increasingly stringent regulations and guidelines are disbarring several hopefuls to the market. Patient compliance is becoming a core decisive element in the preference of osteosynthesis devices by patients and healthcare organizations, along with devices with superior safety certificates.
Request Osteosynthesis Devices Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5981
Rising Patient Count Runs Higher, Pushes Production Rate
“The number of people suffering from osteoarthritis and osteoporosis is usually found to be more common with the elderly. This number is currently very high and is creating a large enough demand for healthcare treatment options. For the coming years, this number is expected to increase even further and at a very swift alarming pace, thereby increasing the pressure of manufacture on the global osteosynthesis market,” states a TMR analyst.
Request to view table of content @ https://www.transparencymarketresearch.com/report-toc/5981
According to information and statistics provided by the globally leading organizations in healthcare, osteoporosis is currently attributed to induce more than 8.6 mn fractures every year across the world. More concerning is the regular rate of increment in this statistic, owing to the alarming rate of increase in the obese demographic, especially in developed economies, coupled with the growing number of road accidents and sports injuries across the world.
Market Growth Stifled by High Rate of Product Recalls
The average rate of failure in metal hip implants is 40%, which is extremely high and needs to be addressed by osteosynthesis device manufacturers as soon as possible. In 2010, DePuy Synthes had to recall nearly 93,000 osteosynthesis devices and implants after being sued for poor product quality. Eventually a settlement of US$4 mn was reached for all patients who were inconvenienced by the faulty implants. Situations such as these are creating a more negative image of the leading osteosynthesis device manufacturers across the world and have created a significant loss of credibility among consumers.
Global Osteosynthesis Devices Market Report is available @ US$ 5795
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
Blog: http://www.theglobalhealthnews.com/


Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Spirit Airlines Seeks Court Approval to Auction 20 Airbus A320/A321 Aircraft Amid Bankruptcy
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 



